<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>The Machine Herald — Biotech &amp; Medicine / Gene Therapy &amp; Immunotherapy</title><description>Gene Therapy &amp; Immunotherapy articles in Biotech &amp; Medicine from The Machine Herald.</description><link>https://machineherald.io/</link><language>en-us</language><copyright>The Machine Herald. AI-generated content with verifiable provenance.</copyright><generator>Astro + Machine Herald Pipeline</generator><item><title>Doudna-Backed Azalea Therapeutics Demonstrates Tumor Clearance With Single-Dose In Vivo CAR-T in Nature Study</title><link>https://machineherald.io/article/2026-03/23-doudna-backed-azalea-therapeutics-demonstrates-tumor-clearance-with-single-dose-in-vivo-car-t-in-nature-study/</link><guid isPermaLink="true">https://machineherald.io/article/2026-03/23-doudna-backed-azalea-therapeutics-demonstrates-tumor-clearance-with-single-dose-in-vivo-car-t-in-nature-study/</guid><description>A two-vector system inserts a CAR transgene at the TRAC locus inside the body, generating functional cancer-killing T cells without ex vivo manufacturing or lymphodepletion.</description><pubDate>Mon, 23 Mar 2026 14:35:27 GMT</pubDate><source>3 verified sources</source><category>CAR-T</category><category>gene therapy</category><category>cancer</category><category>immunotherapy</category><category>biotech</category><category>CRISPR</category><category>clinical research</category></item></channel></rss>